[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0471794T3 - Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer - Google Patents

Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer

Info

Publication number
DK0471794T3
DK0471794T3 DK90909103.5T DK90909103T DK0471794T3 DK 0471794 T3 DK0471794 T3 DK 0471794T3 DK 90909103 T DK90909103 T DK 90909103T DK 0471794 T3 DK0471794 T3 DK 0471794T3
Authority
DK
Denmark
Prior art keywords
thiazine
dyes
xanthene dyes
antiviral therapy
dye
Prior art date
Application number
DK90909103.5T
Other languages
Danish (da)
English (en)
Inventor
Raymond F Schinazi
Robert A Floyd
Original Assignee
Oklahoma Med Res Found
Raymond F Schinazi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996594&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0471794(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oklahoma Med Res Found, Raymond F Schinazi filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of DK0471794T3 publication Critical patent/DK0471794T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90909103.5T 1989-05-11 1990-05-11 Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer DK0471794T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35038389A 1989-05-11 1989-05-11
US38900789A 1989-08-03 1989-08-03

Publications (1)

Publication Number Publication Date
DK0471794T3 true DK0471794T3 (da) 1996-11-18

Family

ID=26996594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909103.5T DK0471794T3 (da) 1989-05-11 1990-05-11 Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer

Country Status (8)

Country Link
EP (1) EP0471794B1 (de)
JP (2) JPH07119173B2 (de)
AT (1) ATE143596T1 (de)
CA (1) CA2055463C (de)
DE (2) DE69028775T2 (de)
DK (1) DK0471794T3 (de)
ES (1) ES2032742T3 (de)
WO (1) WO1990013296A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6090043A (ja) * 1983-10-21 1985-05-21 Nippon Shokubai Kagaku Kogyo Co Ltd 窒素酸化物浄化用触媒
DE3930510A1 (de) * 1989-09-13 1991-03-21 Blutspendedienst Dt Rote Kreuz Verfahren zur inaktivierung von viren in blut und blutprodukten
US5545516A (en) * 1990-05-01 1996-08-13 The American National Red Cross Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light
WO1991016911A1 (en) * 1990-05-01 1991-11-14 The American National Red Cross Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light
US6207107B1 (en) 1992-10-05 2001-03-27 Baxter International Inc. Steam sterilizable system for inactivating viral contaminants in body fluids
US5660731A (en) * 1994-11-08 1997-08-26 Pall Corporation Filter for separating photoactive agent
AT406778B (de) * 1996-04-09 2000-09-25 Immuno Ag Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
US8974363B2 (en) 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US6248733B1 (en) 1998-01-09 2001-06-19 3M Innovative Properties Company Method for limiting the growth of microorganisms using metal-containing compounds
US8557298B2 (en) 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US6610436B1 (en) 1998-09-11 2003-08-26 Gore Enterprise Holdings Catalytic coatings and fuel cell electrodes and membrane electrode assemblies made therefrom
AU7057200A (en) 1999-08-13 2001-03-13 Photogen, Inc. Improved topical medicaments and methods for photodynamic treatment of disease
US6432396B1 (en) 2000-07-06 2002-08-13 3M Innovative Properties Company Limiting the presence of microorganisms using polymer-bound metal-containing compositions
CA2547556A1 (en) * 2003-11-28 2005-06-16 Photopharmica Limited Developments in biologically active methylene blue derivatives (2)
US20050192267A1 (en) * 2004-02-20 2005-09-01 Hofmann Robert F. Use of targeted oxidative therapeutic formulation in treatment of viral diseases
CN101084204B (zh) * 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
WO2006032879A2 (en) * 2004-09-23 2006-03-30 Wista Laboratories Ltd. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
US20060188866A1 (en) * 2005-02-18 2006-08-24 Children's Hospital Oakland Research Institute Diaminophenothiazine compositions and uses thereof
FR2899088B1 (fr) * 2006-03-31 2008-06-27 Mauna Kea Technologies Soc Par "microscopie de fluorescence fibree a base de bleu de methylene."
WO2011137447A1 (en) 2010-04-30 2011-11-03 Prostetta Antiviral Inc. Antiviral compounds
EP2699241B1 (de) 2011-04-20 2016-07-27 Prosetta Antiviral Inc. Antivirale verbindungen
JP7512409B6 (ja) * 2020-03-26 2024-07-23 プロヴェクタス ファーマテック，インク． 腫瘍学及びウイルス学におけるハロゲン化キサンテンの新規の使用
US11938182B2 (en) 2020-03-26 2024-03-26 Provectus Pharmatech, Inc. Halogenated xanthenes as vaccine adjuvants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA993795A (en) * 1970-12-10 1976-07-27 Richardson-Merrell (Canada) Ltd. Antiviral compositions containing bis-basic ethers and thioethers of xanthene and xanthen-9-ones and methods of treating viruses therewith
US4305390A (en) * 1975-11-28 1981-12-15 Massachusetts Institute Of Technology Method for generating oxygen in an excited electronic state and inactivation of microorganisms
DE3341001A1 (de) * 1983-11-12 1985-05-23 Krause, Hans Jürgen Nanopartikel aus bioabbaubarem, synthetischem material, verfahren zu deren herstellung und ihre anwendung

Also Published As

Publication number Publication date
EP0471794B1 (de) 1996-10-02
DE69028775T2 (de) 1997-05-07
JP2700126B2 (ja) 1998-01-19
DE69028775D1 (de) 1996-11-07
ES2032742T1 (es) 1993-03-01
CA2055463C (en) 1997-09-30
DE471794T1 (de) 1992-07-23
EP0471794A1 (de) 1992-02-26
JPH07119173B2 (ja) 1995-12-20
ATE143596T1 (de) 1996-10-15
CA2055463A1 (en) 1990-11-12
JPH04507403A (ja) 1992-12-24
EP0471794A4 (en) 1992-05-06
JPH08151327A (ja) 1996-06-11
WO1990013296A1 (en) 1990-11-15
ES2032742T3 (es) 1997-02-01

Similar Documents

Publication Publication Date Title
DK0471794T3 (da) Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer
ATE146968T1 (de) Verwendung von funkionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie
BR8705535A (pt) Polipeptideos derivados do gene de tegumento de virus de imunodeficiencia humana em celulas de insetos infectados por baculovirus
PT89838A (pt) Processo para a preparacao de agente terapeutico susceptivel de formar um complexo com glicoproteina de involucro de virus de imunodeficiencia humana
DK0459779T3 (da) Immunoreagenser der reagerer med en konserveret epitop af human immundefekt virus type I (HIV-1) gp120 samt fremgangsmåder til anvendelse deraf
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
ATE68349T1 (de) Medizinische verwendung von nukleosiden.
DK155714C (da) Fremgangsmaade til fremstilling af en steril, injicerbar, fysiologisk acceptabel oploesning af et roentgenkontrastmiddel, samt en oploesning af roentgenkontrastmidlet til brug ved fremgangsmaaden
DK430989D0 (da) Transdermalt anvendeligt laegemiddel med et indhold af farmaceutisk anvendelige glykosider
DK442987A (da) 1-aryl-3-tert.butyl-pyrazoler, fremgangsmaader til deres fremstilling samt deres anvendelse til bekaempelse af skadelige organismer
FI901879A0 (fi) Foerfarande foer producering av naturligt hiv-gp160.
ATE59778T1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
DK652187D0 (da) Substituerede 4-aminopyrimidiner, fremgangsmaade til deres fremstilling samt deres anvendelse til bekaempelse af skadelige organismer
DK335987D0 (da) Dna-sekvens, rekombinerede dna-molekyler og fremgangsmaade til fremstilling af newcastle disease virus fussionsprotein eller aekvivalente polypeptider ved fremgangsmaaden opnaaede produkter samt praeparater der indeholder dem
ES2169040T3 (es) Planta resistente a dos o mas virus y preparacion de la misma.
DK135588A (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
ES2088458T3 (es) Fraccion antiviral de extracto acuoso de lentinus edodes.
IT1225262B (it) Metodo per la sensibilizzazione di piccoli animali all'infezione da virus dell'immunodeficienza umana (hiv)
DK14288A (da) Halogenalkyl-, alkenyl- og alkynylazoler, fremgangsmaader til deres fremstilling samt deres anvendelse til bekaempelse af skadelige organismer
DK365489D0 (da) Fremgangsmaade til diagnostisering af hiv-infektion og diagnostiseringsapparat til anvendelse ved fremgangsmaaden
DE69422980D1 (de) Extrakte von Piliostigma thonningii, deren Verwendung und diese enthaltende Zubereitungen
MX154843A (es) Procedimiento para la elaboracion de un preparacao de los factores de coagulacion ii y/o vii de la sangre,que es practicamente seguro frente al virus de la hepatitis
ATE83926T1 (de) Antivirale anwendung von alpha-oligonucleotiden.
ES2054935T3 (es) Actividad anti-vih de bu-3608.
DK380889A (da) Dithiophosphor(phosphon)syreestere, deres fremstilling og anvendelse som midler til bekaempelse af skadelige organismer samt ved fremgangsmaaden anvendelige mellemprodukter